Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem [Yahoo! Finance]
WOLTERS KLUWER S/ADR (WTKWY)
NASDAQ:AMEX Investor Relations:
wolterskluwer.com/investors
Company Research
Source: Yahoo! Finance
Two potent, selective, pre-clinical stage molecules are being advanced as possible treatments for three therapeutic indications Sea's lead SPM-0404 in investigational new drug-enabling studies for tinnitus, epilepsy, and ALS TCG GreenChem will conduct CMC (Chemistry, Manufacturing, & Controls) development on SPM-0404 CAMBRIDGE, MA / ACCESSWIRE / November 14, 2024 / Sea Pharmaceuticals, LLC (Sea) today announced the advancement of two orally-administered neurotherapeutic molecules as potential new medicines for high need neurological disorders. Sea's lead molecule SPM-0404 and a second-generation molecule SPM-0606 are part of a portfolio strategy of discovery and development of novel, potent, selective oral compounds targeting the glutamate pathway. Glutamate is a neurotransmitter in the CNS found in the majority of brain synapses: the specialized contacts where neurons (nerve cells) communicate. Glutamate's action as a neuron-to-neuron signaling molecule is essential for many
Show less
Read more
Impact Snapshot
Event Time:
WTKWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WTKWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WTKWY alerts
High impacting WOLTERS KLUWER S/ADR news events
Weekly update
A roundup of the hottest topics
WTKWY
News
- Wolters Kluwer executive wins two leadership awardsBusiness Wire
- Wolters Kluwer recognized as a Leader in 2024 Gartner® Magic Quadrantâ„¢ for Financial Planning SoftwareBusiness Wire
- Wolters Kluwer and the Australian College of Mental Health Nurses team up to increase mental health resources [Yahoo! Finance]Yahoo! Finance
- Wolters Kluwer and the Australian College of Mental Health Nurses team up to increase mental health resourcesBusiness Wire
- Amid Retail Pharmacy Closures, 59% of Americans Fear Losing Easy Access to Essential Medications, Wolters Kluwer survey shows [Yahoo! Finance]Yahoo! Finance